Godshalk Welsh Capital Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-850
Closed -$228K 134
2016
Q1
$228K Hold
850
0.24% 124
2015
Q4
$266K Sell
850
-150
-15% -$44.7K 0.28% 116
2015
Q3
$272K Buy
+1,000
New +$307K 0.3% 117
2015
Q2
Sell
-1,000
Closed -$298K 146
2015
Q1
$298K Sell
1,000
-50
-5% -$14.3K 0.3% 110
2014
Q4
$270K Buy
+1,050
New +$262K 0.25% 121

Other funds holding AGN

Godshalk Welsh Capital Management's AGN Position: Q2 2016 in Review

Godshalk Welsh Capital Management sold out of Allergan plc (AGN) in Q2 2016, closing a stake of 850 shares — an estimated $228K sold.

Godshalk Welsh Capital Management first reported a position in AGN in Q4 2014 and held it in 5 quarters. The position peaked at $298K in Q1 2015. 1,107 funds tracked by Wall St. Rank hold AGN as of Q2 2016.

  • Godshalk Welsh Capital Management reported no remaining Allergan plc position as of Q2 2016 after selling out during the quarter.
  • Godshalk Welsh Capital Management sold 850 Allergan plc shares in Q2 2016, an estimated $228K.
  • Godshalk Welsh Capital Management first reported a position in Allergan plc in Q4 2014 and held it in 5 quarters.
  • Godshalk Welsh Capital Management's Allergan plc position peaked at $298K in Q1 2015.
  • 1,107 funds tracked by Wall St. Rank held Allergan plc as of Q2 2016.

Based on Godshalk Welsh Capital Management's 13F filing for Q2 2016, filed 12 Aug 2016.